SIStockInvestingSI.com

NYSE · CNC · Healthcare Plans

Centene Corporation (CNC) stock analysis

$70.24−0.80%Data as of Oct 21, 2026
  • CNC gained 11.0% over the past month versus 0.0% for the S&P 500, ranking 49th of 497 S&P 500 stocks.
  • Over 12 months it returned +97.2%, 81.4 points ahead of the S&P 500, and trades 0.8% below its 52-week high.
  • In the last 30 days 1 analyst raised earnings estimates and 1 cut; forward EPS moved +0.7% (+19.5% over 90 days).
  • It sits in the Patients, insurers & government segment of the Medtech, Diagnostics & Care, where the 1-month median return is +11.0%.
  • The daily chart reads Trend transition · Trend repair (since Oct 13, 2026).
Market cap$34.7B
12-month return+97.2%
Forward P/E13.2×
Mean target vs price+2.2%

One-year price with 50- and 200-day averages

Open in Hub
34.945.856.867.7JanAprJulOct
70.2450-day200-day

Performance vs the market

Total price return against the S&P 500 (SPY) and the median of US stocks in the same sector.

CNC+11.0%
Sector median−8.7%
S&P 5000.0%
CNC+10.2%
Sector median−5.4%
S&P 500+4.7%
CNC+80.4%
Sector median−1.5%
S&P 500+8.7%
CNC+97.2%
Sector median+1.7%
S&P 500+15.8%
1-month rank in the S&P 50049 / 497
3-month rank in its sector · Healthcare213 / 720

Chart structure

Read by our daily-bar structure engine from swing highs, swing lows and moving averages.

Trend transition · Trend repairAwaiting confirmation

Holding since Oct 13, 2026

  • Close above EMA20 above EMA50
  • EMA50 rose over the last ten sessions
  • Confirmed swing highs and lows are rising
  • Intermediate and long-term directions differ
  • Neither a stable trend nor a range is confirmed
This pattern on this stock

52 occurrences in 10 years. The median move over the next 20 sessions was −1.0%, positive 42% of the time, against +1.0% for any day in the same period.

Reference zone, stop and targets for this structureSee the trade plan in Hub ↗

Analyst earnings revisions

Changes to the consensus forward-EPS estimate. Rising estimates mean analysts see more profit ahead.

Forward EPS$5.35
30-day change+0.7%
90-day change+19.5%
Mean target$71.78 +2.2%
Raised (30d) 1Cut (30d) 1

18 analysts cover the stock

Where it sits in the supply chain

Medtech, Diagnostics & Care · Patients & payers

Explore the full chain map in Hub
Supplied by
Clinical laboratory services+3.0%
LH+3.9%1 monthDGX+2.2%1 month
Hospitals & dialysis+2.0%
HCA+4.9%1 monthUHS+2.0%1 monthDVA−3.8%1 month
Medical & dental distribution−2.8%
HSIC−2.8%1 month
Its segment
Patients, insurers & government+11.0%
CNC+11.0%1 monthUNH+11.8%1 monthELV+7.9%1 month

Patients and payment systems shape access and utilization; payers are not device suppliers.

Figures are each company's 1-month return; the segment shows its median · Doubler daily batch · company chain maps

Risk profile

Max drawdown, 12M−32.7%
Volatility, 60D33.9%
From 52-week high−0.8%
From 52-week low+120.9%
Forward P/E13.2×

Track this stock every day

Hub adds the daily brief, StockFlow factor flow, trade plans and alerts for your watchlist.

Open in Hub ↗